Ultragenyx Pharmaceutical, Inc. (RARE)
36.10
-0.20
(-0.55%)
USD |
NASDAQ |
Dec 10, 15:11
Ultragenyx Pharmaceutical Market Cap: 3.483B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 75.72B |
| Amicus Therapeutics, Inc. | 3.048B |
| Geron Corp. | 817.09M |
| Ionis Pharmaceuticals, Inc. | 12.83B |
| Vertex Pharmaceuticals, Inc. | 112.44B |
Market Cap Related Metrics
| PS Ratio | 5.584 |
| Price to Book Value | 380.26 |
| Price | 36.10 |
| Earnings Yield | -16.45% |